Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Inflamm Bowel Dis. 2016 Jan;22(1):224–233. doi: 10.1097/MIB.0000000000000589

Figure 2.

Figure 2

Monitoring of MTX therapy * currently not recommended by guidelines but may be a reasonable approach based on current literature.42, 102, 104

Liver biopsy: Not generally recommended except for persistent elevation of Liver function tests. * Consider Liver elastography as a monitoring tool especially for patients with risk factors such as obesity, NAFLD and alcohol consumption.